Patient Capital Management’s Silvergate Capital Corporation SI Stock Holding History

Patient Capital Management’s Portfolio SI Stock Details SI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-135,600	Closed	-$2.36M	–	44
2022 Q4	$2.36M	Buy	+135,600	New	+$5.38M	1.15%	33

Other funds holding SI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Patient Capital Management's SI Position: Q1 2023 in Review

Patient Capital Management sold out of Silvergate Capital Corporation (SI) in Q1 2023, closing a stake of 135,600 shares — an estimated $2.36M sold.

Patient Capital Management first reported a position in SI in Q4 2022 and held it in 1 quarter. The position peaked at $2.36M in Q4 2022. 112 funds tracked by Wall St. Rank hold SI as of Q1 2023.

Patient Capital Management reported no remaining Silvergate Capital Corporation position as of Q1 2023 after selling out during the quarter.
Patient Capital Management sold 135,600 Silvergate Capital Corporation shares in Q1 2023, an estimated $2.36M.
Patient Capital Management first reported a position in Silvergate Capital Corporation in Q4 2022 and held it in 1 quarter.
Patient Capital Management's Silvergate Capital Corporation position peaked at $2.36M in Q4 2022.
112 funds tracked by Wall St. Rank held Silvergate Capital Corporation as of Q1 2023.

Based on Patient Capital Management's 13F filing for Q1 2023, filed 15 May 2023.